Clinical Trials Sponsored by Catalyst Pharmaceutical Partners, Inc
Total 15 results
-
Catalyst Pharmaceuticals, Inc.Active, not recruitingMyasthenia Gravis, MuSKUnited States
-
Catalyst Pharmaceuticals, Inc.CompletedMyasthenic Syndromes, CongenitalUnited States
-
Catalyst Pharmaceuticals, Inc.TerminatedMethamphetamine DependenceUnited States
-
Catalyst Pharmaceuticals, Inc.CompletedMyasthenia Gravis, GeneralizedUnited States
-
Catalyst Pharmaceuticals, Inc.Completed
-
Catalyst Pharmaceuticals, Inc.TerminatedSpinal Muscular Atrophy Type 3Italy
-
Catalyst Pharmaceuticals, Inc.No longer availableLambert-Eaton Myasthenic Syndrome | Congenital Myasthenic Syndrome | Nystagmus, AcquiredUnited States
-
Catalyst Pharmaceuticals, Inc.CompletedMuscular Atrophy, SpinalItaly
-
Catalyst Pharmaceuticals, Inc.Completed
-
Catalyst Pharmaceuticals, Inc.CompletedLambert-Eaton Myasthenic SyndromeUnited States
-
Catalyst Pharmaceuticals, Inc.CompletedA Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)Lambert Eaton Myasthenic SyndromeUnited States, Spain, Serbia, Russian Federation, Hungary, France, Germany, Poland
-
NYU Langone HealthCatalyst Pharmaceuticals, Inc.Completed
-
Ricardo MaselliCatalyst Pharmaceuticals, Inc.No longer availableCongenital Myasthenic SyndromeUnited States
-
Catalyst Pharmaceuticals, Inc.National Institute on Drug Abuse (NIDA); VA Office of Research and DevelopmentCompletedCocaine Dependence | Cocaine AddictionUnited States
-
Santalis Pharmaceuticals, Inc.Derm Research, PLLC; ClinDatrix, Inc.; Texas Dermatology and Laser Specialists; Clinical Trials of Texas, Inc... and other collaboratorsCompletedEczema | Atopic DermatitisUnited States